AbCellera Biologics Inc. (ABCL)

SEC FORM 4

$570,442.32

Purchase of 53,613 shares at $10.64 per share.

Reporting Person Hayden Michael R · Transaction Code P

Traded Aug 24, 2026 · Disclosed Aug 24, 2026

Source: SEC Form 4 · 0001628280-26-058684 · filed 2026-08-24 · View filing →

SEC FORM 4CLUSTER · 3 INSIDERS

$975,237.19

Purchase of 93,587 shares across 3 reporting persons.

Transaction Code P · Reporting Persons 3

Hayden Michael RPurchase of 46,387 shares at $10.37 per share.$481,033.19
Booth Andrew, Chief Financial OfficerPurchase of 37,200 shares at $10.32 per share.$383,904.00
Montalbano John S.Purchase of 10,000 shares at $11.03 per share.$110,300.00

Surfaced by rule: 3 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.

Traded Aug 12, 2026 · Disclosed Aug 18, 2026FILED +6 DAYS

Source: SEC Form 4 · 0001628280-26-057007 · filed 2026-08-14 · View filing →

Source: SEC Form 4 · 0001834411-26-000008 · filed 2026-08-14 · View filing →

Source: SEC Form 4 · 0001834423-26-000008 · filed 2026-08-18 · View filing →